Metastatic urothelial carcinoma
From Infogalactic: the planetary knowledge core
Lua error in package.lua at line 80: module 'strict' not found.
The following considers the results of Chemotherapy on Metastatic urothelial carcinoma.
"Patients with refractory advanced or metastatic urothelial carcinoma derive only minor benefit from chemotherapy".[1]
Various studies have shown combination chemotherapy to have an effect. Treatment with chemotherapy and "infusion cisplatin and high-dose 5-fluorouracil/leucovorin (P-HDFL)" results in a median survival of 38 months.[2]
Donald Kaufman worked on a study using a combination of gemcitabine and cisplatin, which resulted in a median survival of 14.3 months.[3]
Generally speaking, treatment with chemotherapy will not with any amount of certainty, extend one's life.
